Head of Division: Irwin McLean
Secretary: Diane Purves
Lab Manager: Marianne Reilly

The Division of Molecular Medicine bridges the two Colleges of Life Sciences and Medicine, Dentistry & Nursing. Its strategic aims are (i) to further strengthen the research ties between the two Colleges; (ii) to facilitate translation of basic science discoveries into improvements in health and quality of life; and (iii) to develop and deliver new medicines.  The Division’s main target diseases for experimental medicine development are cancer and skin disease.

The research groups within the Division have substantial funding from Cancer Research UK, The Medical Research Council and The Wellcome Trust, as well as a number of charities active in the area of inherited disease, particularly The Dystrophic Epidermolysis Bullosa Research Association (DEBRA), Pachyonychia Congenita Project (PC Project), The British Skin Foundation, The National Eczema Society and Fight for Sight.

The work of the Division is focussed on: functions of the p53 system and its exploitation for development of new anti-cancer drugs; development of therapeutic antibodies for cancer and other diseases; identification of genes involved in human skin disease; cytoskeleton systems in tissue homeostasis and specialized functions; development of RNA-interference and small molecule drug therapies.